Alternative mechanisms of multidrug resistance in cancer
著者
書誌事項
Alternative mechanisms of multidrug resistance in cancer
Birkhäuser, c1995
大学図書館所蔵 全5件
  青森
  岩手
  宮城
  秋田
  山形
  福島
  茨城
  栃木
  群馬
  埼玉
  千葉
  東京
  神奈川
  新潟
  富山
  石川
  福井
  山梨
  長野
  岐阜
  静岡
  愛知
  三重
  滋賀
  京都
  大阪
  兵庫
  奈良
  和歌山
  鳥取
  島根
  岡山
  広島
  山口
  徳島
  香川
  愛媛
  高知
  福岡
  佐賀
  長崎
  熊本
  大分
  宮崎
  鹿児島
  沖縄
  韓国
  中国
  タイ
  イギリス
  ドイツ
  スイス
  フランス
  ベルギー
  オランダ
  スウェーデン
  ノルウェー
  アメリカ
注記
Includes bibliographical references and index
内容説明・目次
- 巻冊次
-
ISBN 9780817637750
内容説明
Nullius in verba. . . Truth will be tested not by words. Horace (Epistles) Few read introductions except for book reviewers, who want to take a shortcut and avoid reading the book itself. However, tradition requires that the preface make public why the book was written at all (this is not supposed to include powerful reasons such as augmenting the ego of the editor and authors). Frequently, the inflationary tendency to publish in verbose length is in conflict with market forces and interest. No doubt, multidrug resistance is a "fashionable" topic, but there are many fashions displayed on the cat-walk of scientific literature. One can rationalize that the forces driving our concern with multi drug resistance reflect the frustration of pharmaceutical companies and oncologists alike: as soon as a new anticancer drug enters clinical trials, cancer cells start eluding extinction with their elaborate and successful mechanisms. Many grants have been awarded and spent, only to confirm the futility of our efforts to defeat this cellular Darwinism. Our medical and scientific training makes it hard, if not impossible, to accept that the survival of a malignant cell, alone or as part of a tissue, is part of the continuance of life. Since exposure to noxious and lethal substances is unavoidable, cells have been forced to develop a multitude of mechanisms to prevent entry or accelerate exit of such materials from intracellular space.
目次
1. Mechanisms of Multidrug Resistance.- 2. The Role of Glutathione S-Transferases in Drug Resistance.- 3. Pharmacology of Drug Transport in Multidrug Resistant Tumor Cells.- 4. The Multidrug Resistance-Associated Protein MRP.- 5. Topoisomerases in Multidrug Resistance.- 6. Genotoxicity of Topoisomerase II Inhibitors-Consequences of Chemotherapy.- 7. A Distinctive Multiple Drug Resistance Phenotype in Tumor Cells Exposed to X-Irradiation.- 8. Taxoids and Multidrug Resistance.- 9. The Contribution of Protein Kinase C to Multiple Drug Resistance in Cancer.- 10. Bcl-2 and Chemoresistance in Cancer.- 11. Molecular Interrelationships in Multidrug Resistance.- 12. Platinum Resistance in Human Carcinomas.- Perspectives.- Conclusions.
- 巻冊次
-
ISBN 9783764337759
内容説明
Drug resistance, whatever its source, is the prevalent cause for treatment failure in cancer chemotherapy. At present, the best understood (and most publicized) mechanism of cell resistance is the P-glycoprotein mediated efflux pump. However, it is not the only - or even the most effective - tool of survival devices to be considered in this book. Alterations of topoisomerases and conjugases, glutathione transferases, protein kinase C, the multidrug resistance protein MRP, bc12 and other modes of action are considered as well. By identifying and understanding how multidrug resistance in cancer evolves and functions, we should be able to prevent, circumvent or reverse this so far inescapable phenomenon. Featuring a collection of reviews by scientists, this book attempts to achieve an understanding of the molecular basis for drug resistance. It is intended for researchers in such diverse fields as chemotherapy, drug delivery, oncology, pathology, pharmacokinetics, tumour biology and biological response modifiers.
目次
- Mechanisms of Multidrug Resistance, J.A. Kellen
- The Role of Glutathione S-Transferases in Drug Resistance, W. T. Bellamy
- Pharmacology of Drug Transport in Multidrug Resistant in Tumor Cells, H.J. Broxterman and C.H. Versantvoort
- The Multidrug Resistance-Associated Protein MRP, D. Fan, D.R. Bielenberg, Y.F. Wang, R. Radinsky, and P.J. Beltran
- Topoisomerases in Multidrug Resistance, T. Utsugi, C.E. Herzog, and D. Fan
- Genotoxicity of Topoisomerases 11 Inhibitors-Consequences of Chemotherapy, F. Gieseler
- A Distinctive Multiple Drug Resistance Phenotype in Tumor Cells Exposed to X-Irradiation, B. T. Hill
- Taxoids and Multidrug Resistance, R.A.Newman and D. Fan
- The Contribution of Protein Kinase C to Multiple Drug Resistance in Cancer, C.A. O'Brian, N.E. Ward, K.P. Gupta, and K.R. Gravitt
- Bcl-2 and Chemoresistance in Cancer, J. C. Reed
- Molecular Interrelationships in Multidrug Resistance, J.A. Kellen
- Platinum Resistance in Human Carcinomas, H. Ishida, H. Kijima, Y. Ohta, M. Kashani-Sabet, and K.J. Scanlon.
「Nielsen BookData」 より